# MTMR3

## Overview
MTMR3 is a gene that encodes the myotubularin-related protein 3, a member of the myotubularin family of phosphatases. This protein is characterized by its phosphoinositide 3-phosphatase activity, which plays a crucial role in the regulation of phosphoinositide signaling pathways. Myotubularin-related protein 3 is involved in the hydrolysis of phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), contributing to the production of phosphatidylinositol 5-phosphate (PtdIns5P) (Walker2001Characterization; Oppelt2012Production). This enzymatic activity is essential for various cellular processes, including cell migration, autophagy, and immune response modulation. MTMR3 is ubiquitously expressed and localizes to both the cytosol and reticular structures, such as the endoplasmic reticulum, influencing cellular dynamics and signaling pathways (Robinson2006Myotubularin). The gene has been implicated in several diseases, including autoimmune disorders and cancer, highlighting its clinical significance in pathophysiological contexts (Elhelaly2023Breast; Senousy2019Association).

## Structure
MTMR3 is a member of the myotubularin family of phosphatases and is characterized by several distinct domains. It contains an N-terminal PH-GRAM domain, a signature catalytic phosphatase domain, and a C-terminal FYVE domain (Lorenzo2005Analysis; Begley2005The). The PH-GRAM domain is involved in binding phosphoinositide lipids, with a preference for PtdIns5P, and is crucial for the enzyme's activity and subcellular localization (Lorenzo2005Analysis). The FYVE domain in MTMR3 is atypical as it does not bind PtdIns3P and does not confer endosomal localization (Lorenzo2005Analysis; Begley2005The).

The molecular structure of MTMR3 includes a coiled-coil region, which is common among myotubularin family members (Begley2005The). The protein is involved in phosphoinositide metabolism, specifically hydrolyzing PtdIns3P and PtdIns(3,5)P2 (Robinson2006Myotubularin). MTMR3 is ubiquitously expressed and shows both cytosolic and reticular localization, overlapping with the endoplasmic reticulum (Robinson2006Myotubularin). Mutations, such as the catalytic cysteine mutation (C413S), can lead to the formation of vacuolar structures resembling autophagosomes (Lorenzo2005Analysis). The protein may undergo post-translational modifications, including phosphorylation, and alternative splicing can result in different isoforms (Begley2005The).

## Function
MTMR3 is a phosphoinositide 3-phosphatase involved in the regulation of phosphoinositide signaling pathways. It specifically dephosphorylates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), contributing to the production of phosphatidylinositol 5-phosphate (PtdIns5P) (Walker2001Characterization; Oppelt2012Production). This activity is crucial for various cellular processes, including cell migration, where MTMR3 influences cell motility and polarization by affecting the actin cytoskeleton and Golgi orientation (Oppelt2012Production).

MTMR3 also plays a significant role in autophagy regulation. It interacts with mTORC1, a key regulator of cell growth and autophagy, and suppresses its activity, which can lead to increased autophagy when MTMR3 is overexpressed (Hao2015The). The protein is largely cytosolic but can localize to the Golgi and endoplasmic reticulum, influencing cellular localization dynamics (Hao2015The; Walker2001Characterization).

In the immune system, MTMR3 modulates cytokine secretion and signaling pathways, such as NFκB and PI3K, which are essential for immune responses. It is involved in regulating autophagy and cytokine production in response to pattern recognition receptor stimulation, impacting inflammatory processes (Lahiri2015MTMR3).

## Clinical Significance
MTMR3 has been implicated in several diseases due to mutations, altered expression levels, or changes in its interactions. In systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), the rs12537 SNP in the MTMR3 gene is associated with increased disease risk and severity. This SNP is linked to decreased MTMR3 mRNA levels and increased autophagy marker levels, suggesting a role in deregulated autophagy in these autoimmune diseases (Senousy2019Association). In lupus nephritis, MTMR3 is identified as a susceptibility gene, with the SNP rs9983A showing significant association with the disease in the northern Han Chinese population (Zhou2014Brief).

MTMR3 is also associated with breast cancer risk. The rs12537 SNP, particularly the 'T/T' genotype, is linked to higher odds of developing breast cancer. This genotype is associated with increased MTMR3 expression, which may negatively impact survival by reducing autophagy (Elhelaly2023Breast). In inflammatory bowel disease (IBD), the rs713875 polymorphism increases MTMR3 expression, enhancing cytokine secretion and contributing to disease pathogenesis (Lahiri2015MTMR3). These findings highlight MTMR3's role in the pathophysiology of various autoimmune and inflammatory disorders.

## Interactions
MTMR3, a member of the myotubularin family, participates in various protein interactions that influence its role in cellular processes. It interacts with mTORC1, a serine/threonine kinase complex, and suppresses its activity. This interaction is mediated by the N-terminal half of MTMR3, which includes the PH-G and phosphatase domains, and is independent of its phosphatase activity (Hao2015The). MTMR3 also interacts with polo-like kinase 1 (PLK1) and centrosomal protein of 55 kDa (CEP55), playing a crucial role in cytokinesis and abscission. These interactions are essential for proper cell division, as disruption leads to abscission defects (StDenis2015Myotubularinrelated).

MTMR3 forms heteromeric interactions with MTMR4, another myotubularin-related protein. This interaction affects the subcellular distribution of MTMR4 and is involved in regulating endosomal functions (Lorenzo2006Systematic). MTMR3's interaction with MTMR4 is specific and does not follow the typical pattern of pairing an active with an inactive family member (Lorenzo2006Systematic). These interactions highlight MTMR3's role in cellular signaling pathways, particularly in processes like autophagy and cytokinesis.


## References


[1. (StDenis2015Myotubularinrelated) Nicole St-Denis, Gagan D. Gupta, Zhen Yuan Lin, Beatriz Gonzalez-Badillo, Laurence Pelletier, and Anne-Claude Gingras. Myotubularin-related proteins 3 and 4 interact with polo-like kinase 1 and centrosomal protein of 55 kda to ensure proper abscission. Molecular &amp; Cellular Proteomics, 14(4):946–960, April 2015. URL: http://dx.doi.org/10.1074/mcp.m114.046086, doi:10.1074/mcp.m114.046086. This article has 18 citations.](https://doi.org/10.1074/mcp.m114.046086)

[2. (Elhelaly2023Breast) Mona Elhelaly, Olfat G. Shaker, Ghada Ayeldeen, Alyaa R. Elsergany, and Nora Mostafa. Breast cancer risk is associated with the hulc rs7763881, mtmr3 rs12537 polymorphisms, and serum levels of hulc and mtmr3 in egyptian patients. Molecular Biology Reports, 50(12):10073–10081, November 2023. URL: http://dx.doi.org/10.1007/s11033-023-08897-1, doi:10.1007/s11033-023-08897-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-023-08897-1)

[3. (Senousy2019Association) Mahmoud A. Senousy, Hebatullah S. Helmy, Nevine Fathy, Olfat G. Shaker, and Ghada M. Ayeldeen. Association of mtmr3 rs12537 at mir-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in egyptian patients. Scientific Reports, August 2019. URL: http://dx.doi.org/10.1038/s41598-019-48770-5, doi:10.1038/s41598-019-48770-5. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-48770-5)

[4. (Robinson2006Myotubularin) Fred L. Robinson and Jack E. Dixon. Myotubularin phosphatases: policing 3-phosphoinositides. Trends in Cell Biology, 16(8):403–412, August 2006. URL: http://dx.doi.org/10.1016/j.tcb.2006.06.001, doi:10.1016/j.tcb.2006.06.001. This article has 196 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tcb.2006.06.001)

[5. (Begley2005The) Michael J Begley and Jack E Dixon. The structure and regulation of myotubularin phosphatases. Current Opinion in Structural Biology, 15(6):614–620, December 2005. URL: http://dx.doi.org/10.1016/j.sbi.2005.10.016, doi:10.1016/j.sbi.2005.10.016. This article has 72 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.sbi.2005.10.016)

[6. (Lorenzo2006Systematic) Óscar Lorenzo, Sylvie Urbé, and Michael J. Clague. Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosomerelated functions. Journal of Cell Science, 119(14):2953–2959, July 2006. URL: http://dx.doi.org/10.1242/jcs.03040, doi:10.1242/jcs.03040. This article has 71 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.03040)

[7. (Walker2001Characterization) Donna M. Walker, Sylvie Urbé, Stephen K. Dove, Danielle Tenza, Graça Raposo, and Michael J. Clague. Characterization of mtmr3. Current Biology, 11(20):1600–1605, October 2001. URL: http://dx.doi.org/10.1016/s0960-9822(01)00501-2, doi:10.1016/s0960-9822(01)00501-2. This article has 117 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0960-9822(01)00501-2)

[8. (Lahiri2015MTMR3) Amit Lahiri, Matija Hedl, and Clara Abraham. Mtmr3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation. Proceedings of the National Academy of Sciences, 112(33):10461–10466, August 2015. URL: http://dx.doi.org/10.1073/pnas.1501752112, doi:10.1073/pnas.1501752112. This article has 32 citations.](https://doi.org/10.1073/pnas.1501752112)

[9. (Zhou2014Brief) Xu‐jie Zhou, Swapan K. Nath, Yuan‐yuan Qi, Fa‐juan Cheng, Hai‐zhen Yang, Yan Zhang, Wanling Yang, Jian‐yang Ma, Ming‐hui Zhao, Nan Shen, and Hong Zhang. Brief report: identification of mtmr3 as a novel susceptibility gene for lupus nephritis in northern han chinese by shared‐gene analysis with iga nephropathy. Arthritis &amp; Rheumatology, 66(10):2842–2848, September 2014. URL: http://dx.doi.org/10.1002/art.38749, doi:10.1002/art.38749. This article has 42 citations.](https://doi.org/10.1002/art.38749)

[10. (Hao2015The) Feike Hao, Takashi Itoh, Eiji Morita, Kanae Shirahama‐Noda, Tamotsu Yoshimori, and Takeshi Noda. The ptdins3‐phosphatase mtmr3 interacts with mtorc1 and suppresses its activity. FEBS Letters, 590(1):161–173, December 2015. URL: http://dx.doi.org/10.1002/1873-3468.12048, doi:10.1002/1873-3468.12048. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1873-3468.12048)

[11. (Lorenzo2005Analysis) Óscar Lorenzo, Sylvie Urbé, and Michael J. Clague. Analysis of phosphoinositide binding domain properties within the myotubularin-related protein mtmr3. Journal of Cell Science, 118(9):2005–2012, May 2005. URL: http://dx.doi.org/10.1242/jcs.02325, doi:10.1242/jcs.02325. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.02325)

[12. (Oppelt2012Production) Angela Oppelt, Viola H Lobert, Kaisa Haglund, Ashley M Mackey, Lucia E Rameh, Knut Liestøl, Kay Oliver Schink, Nina Marie Pedersen, Eva M Wenzel, Ellen M Haugsten, Andreas Brech, Tor Erik Rusten, Harald Stenmark, and Jørgen Wesche. Production of phosphatidylinositol 5‐phosphate via pikfyve and mtmr3 regulates cell migration. EMBO reports, 14(1):57–64, November 2012. URL: http://dx.doi.org/10.1038/embor.2012.183, doi:10.1038/embor.2012.183. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/embor.2012.183)